Information Provided By: 
Fly News Breaks for August 20, 2015
OMED, VSTM, TSRO
Aug 20, 2015 | 05:48 EDT
Mizuho analyst Peter Lawson says his three favorite biotech stocks for the second half of 2015 remain TESARO (TSRO), Verastem (VSTM) and OncoMed (OMED). Key near-term catalysts include Verastem's VS-6063 interim analysis in Q2, TESARO's September 5 FDA action date for rolapitant and the "emerging flow of data" from OncoMed's pipeline, Lawson tells investors in a research note.
News For TSRO;VSTM;OMED From the Last 2 Days
There are no results for your query TSRO;VSTM;OMED
